GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grapefruit USA Inc (OTCPK:GPFT) » Definitions » EPS (Diluted)

Grapefruit USA (Grapefruit USA) EPS (Diluted) : $0.00 (TTM As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Grapefruit USA EPS (Diluted)?

Grapefruit USA's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00.

Grapefruit USA's EPS (Basic) for the three months ended in Sep. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00.

Grapefruit USA's EPS without NRI for the three months ended in Sep. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 68.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Grapefruit USA's highest 3-Year average EPS without NRI Growth Rate was 69.80% per year. The lowest was -202.70% per year. And the median was 10.35% per year.


Grapefruit USA EPS (Diluted) Historical Data

The historical data trend for Grapefruit USA's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grapefruit USA EPS (Diluted) Chart

Grapefruit USA Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 -0.25 -0.03 - -0.01

Grapefruit USA Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Sep23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Grapefruit USA's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grapefruit USA's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's PE Ratio falls into.



Grapefruit USA EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Grapefruit USA's Diluted EPS for the fiscal year that ended in Dec. 2021 is calculated as

Diluted EPS (A: Dec. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5.505-0)/515.339
=-0.01

Grapefruit USA's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.37-0)/958.882
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grapefruit USA  (OTCPK:GPFT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Grapefruit USA EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Grapefruit USA's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Grapefruit USA (Grapefruit USA) Business Description

Traded in Other Exchanges
N/A
Address
10866 Wilshire Boulevard, Suite 225, Los Angeles, CA, USA, 90024
Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.
Executives
Bradley J Yourist director, 10 percent owner, officer: Chairman and CEO 10866 WILSHIRE BLVD, #225, LOS ANGELES CA 90024
Daniel J. Yourist director, 10 percent owner, officer: Board of Directors and COO 10866 WILSHIRE BLVD, SUITE 225, LOS ANGELES CA 90024
Dane Medley director, officer: CEO/Chairman 10553 CAMARILLO STREET, TOLUCA LAKE CA 91602
Emilio Xavier Aguilera director, officer: Chief Financial Officer 16827 HALSEY STREET, GRANADA HILLS CA 91344
Dean Janes officer: CHIEF EXECUTIVE OFFICER 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Christopher Sohn director, officer: President and COO 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Xavier Aguilera director, officer: CFO/Treasurer,Exec.V.P.& Secy 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Michele Janes officer: Vice President of Admin. 3200 W. VALHALLA DRIVE, BURBANK CA 91505